CEOs of top gene-editing firms got huge compensation hikes last year – Boston Business Journal
Boston Business Journal |
CEOs of top gene-editing firms got huge compensation hikes last year
Boston Business Journal It's no secret that the burgeoning field of gene-editing — a method of cutting out and replacing part of a gene — has generated serious buzz in the biotech world lately. New scientific tools like CRISPR/Cas9 have the potential to revolutionize the … CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with … CRISPR Therapeutics, Casebia ink AAV deal with StrideBio; Puma gets an AdComm date; Merrimack names new R&D … Crispr Therapeutics AG (CRSP) Given Consensus Recommendation of “Strong Buy” by Analysts |
